Mga Batayang Estadistika
| LEI | 5493001Z5YYT109QZ980 |
| CIK | 849146 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to LifeVantage Corporation
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| September 4, 2025 |
LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2025 LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2025 Salt Lake City, UT, September 4, 2025, LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its fourth quarter and full fiscal year ended June 30, 2025. |
|
| September 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-35647 LIFEVANTAGE CORPORATIO |
|
| September 4, 2025 |
SUBSIDIARIES OF LIFEVANTAGE CORPORATION Exhibit 21.1 SUBSIDIARIES OF LIFEVANTAGE CORPORATION Set forth below is a list of all subsidiaries of LifeVantage Corporation, a Delaware corporation, and the state or country of incorporation of each as of June 30, 2025. Name State or Country of Incorporation Dinng Creative, Inc. Utah Importadora LifeVantage S. de R.L. de C.V. Mexico LFVN Malaysia SDN. BHD. Malaysia LifeLine Nutraceuticals Corpor |
|
| September 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 4, 2025 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organiz |
|
| September 4, 2025 |
insidertradingpolicy 1 Insider Trading Policy Amended and Restated on April 29, 2025 Introduction LifeVantage Corporation (referred to herein as “LifeVantage” or the “Company”) is a publicly traded company and is subject to United States securities laws which contain very strict prohibitions regarding trading in securities. |
|
| May 6, 2025 |
Evolve Compensation Plan (Philippines) COMPENSATION PLAN GUIDE FOR INDEPENDENT LIFEVANTAGE CONSULTANTS PHILIPPINES Effective 01 March 2025 ©2024 Protandim Philippines Corporation • 02 8 395 3355 • www. |
|
| May 6, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2025 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organization) |
|
| May 6, 2025 |
Evolve Compensation Plan (Taiwan) LIFEVANTAGE獨立顧問獎金計畫 台灣 2025年3月1日下午3時生效 台灣生命優勢有限公司 • 台北市松山區南京東路三段337號11樓C室，郵遞區號10550 • +886(2)5579-8000 lifevantage. |
|
| May 6, 2025 |
Evolve Compensation Plan (Hong Kong) COMPENSATION PLAN GUIDE FOR INDEPENDENT LIFEVANTAGE CONSULTANTS HONG KONG Effective 01 March 2025 ©2024 LifeVantage Hong Kong Limited Suite 2701, 27/F. |
|
| May 6, 2025 |
LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2025 LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2025 Salt Lake City, UT, May 6, 2025, LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its third fiscal quarter ended March 31, 2025. |
|
| May 6, 2025 |
Evolve Compensation Plan (Singapore) Evolve COMPENSATION PLAN GUIDE FOR INDEPENDENT LIFEVANTAGE CONSULTANTS SINGAPORE Effective 1 March 2025 Welcome 2 activatedLife. |
|
| May 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission file number: 001-35647 LIFEVANTAGE CORPORATION |
|
| February 5, 2025 |
Evolve Compensation Plan (Mexico), as amended on November 1, 2024 Evolve GUÍA DEL PLAN DE COMPENSACIÓN PARA CONSULTORES INDEPENDIENTES DE LIFEVANTAGE MÉXICO En vigor a partir del 1 de noviembre de 2024 Bienvenido 2 activatedLa vida es complicada, desordenada y hermosa. |
|
| February 5, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 5, 2025 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organiza |
|
| February 5, 2025 |
Evolve Compensation Plan (Canada), as amended on November 1, 2024 Evolve COMPENSATION PLAN GUIDE FOR INDEPENDENT LIFEVANTAGE CONSULTANTS CANADA Effective November 1, 2024 Welcome 2 activatedLife. |
|
| February 5, 2025 |
Evolve Compensation Plan (United States), as amended on November 1, 2024 Evolve COMPENSATION PLAN GUIDE FOR INDEPENDENT LIFEVANTAGE CONSULTANTS USA Effective November 1, 2024 Welcome 2 activatedLife. |
|
| February 5, 2025 |
Evolve Compensation Plan (New Zealand), as amended on November 1, 2024 Evolve COMPENSATION PLAN GUIDE FOR INDEPENDENT LIFEVANTAGE CONSULTANTS NEW ZEALAND Effective 1 November 2024 Welcome 2 activatedLife. |
|
| February 5, 2025 |
Evolve Compensation Plan (Japan) Evolve ライフバンテージ ライフバンテージの独立コンサルタント向け報酬プランガイド 日本向け 発効日 エボルブ ブックレット 2024年11月1日 Welcome 2 activated人生は、複雑で厄介ですが、それでいて美しい ものです。あっという間に過ぎていくので、一瞬 一瞬を充実させたいと願うものの、日々の生活 やその責任感から、なかなか新たな一歩が踏み 出せないかもしれません。でも私たちは、もっと 自由になって、健やかで幸せな人生を送ってい いのです。 ここにライフバンテージの存在意義がありま す。 当社の製品は、ニュートリゲノミクスによって、 身体が本来持っている、生き生きとした健康を つくり出す力を活用できるように開発されてい ます。 心身ともに最高の自分になったら、その方法をシ ェアしてみませんか？ ライフバンテージは人々の 生活をより良く変える可能性のあるビジネスを、 |
|
| February 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission file number: 001-35647 LIFEVANTAGE CORPORAT |
|
| February 5, 2025 |
Evolve Compensation Plan (Australia), as amended on November 1, 2024 Evolve COMPENSATION PLAN GUIDE FOR INDEPENDENT LIFEVANTAGE CONSULTANTS AUSTRALIA Effective 1 November 2024 Welcome 2 activatedLife. |
|
| February 5, 2025 |
LifeVantage Announces Financial Results for the Second Quarter of Fiscal 2025 LifeVantage Announces Financial Results for the Second Quarter of Fiscal 2025 Salt Lake City, UT, February 5, 2025, LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its second fiscal quarter ended December 31, 2024. |
|
| February 5, 2025 |
Evolve Compensation Plan (UK), as amended on November 1, 2024 Evolve COMPENSATION PLAN GUIDE FOR INDEPENDENT LIFEVANTAGE CONSULTANTS UNITED KINGDOM Effective 1 November 2024 Welcome 2 activatedLife. |
|
| February 5, 2025 |
Evolve Compensation Plan (EU), as amended on November 1, 2024 Evolve COMPENSATION PLAN GUIDE FOR INDEPENDENT LIFEVANTAGE CONSULTANTS EUROPEAN UNION Effective 1 November 2024 Welcome 2 activatedLife. |
|
| November 21, 2024 |
As filed with the Securities and Exchange Commission on November 21, 2024 As filed with the Securities and Exchange Commission on November 21, 2024 Registration No. |
|
| November 21, 2024 |
Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) LifeVantage Corporation (Exact name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule(4) Amount Registered(1) Proposed Maximum Offering Price Per Share Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee(4) Equity Common Stock, par value $0. |
|
| November 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 18, 2024 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organiz |
|
| November 19, 2024 |
Exhibit 3.1 CERTIFICATE OF ELIMINATION OF SERIES A JUNIOR PARTICIPATING PREFERRED STOCK OF LIFEVANTAGE CORPORATION (Pursuant to Section 151(g) of the General Corporation Law of the State of Delaware) LifeVantage Corporation, a Delaware corporation (the “Company”), certifies as follows: 1. The Certificate of Incorporation (the “Charter”) of the Company, including as amended pursuant to that certain |
|
| November 14, 2024 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2024 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organiza |
|
| October 29, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 29, 2024 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organiza |
|
| October 29, 2024 |
LifeVantage Announces Financial Results for the First Quarter of Fiscal 2025 LifeVantage Announces Financial Results for the First Quarter of Fiscal 2025 Salt Lake City, UT, October 29, 2024, LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its first fiscal quarter ended September 30, 2024. |
|
| October 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission file number: 001-35647 LIFEVANTAGE CORPORA |
|
| September 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Prox |
|
| September 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ý Defin |
|
| August 28, 2024 |
LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2024 LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2024 Salt Lake City, UT, August 28, 2024, LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its fourth quarter and full fiscal year ended June 30, 2024. |
|
| August 28, 2024 |
Amended and Restated LifeVantage Corporation 2017 Long-Term Incentive Plan LIFEVANTAGE CORPORATION 2017 LONG-TERM INCENTIVE PLAN (Adopted on December 6, 2016, Effective on February 16, 2017 and Amended on November 16, 2017, January 19, 2018, September 20, 2018, August 27, 2020, September 19, 2022 and September 21, 2023) SECTION 1. |
|
| August 28, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 28, 2024 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organizat |
|
| August 28, 2024 |
Company Policy for the Recovery of Erroneously A LIFEVANTAGE CORPORATION POLICY FOR THE RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION Amended and Restated on November 6, 2023 1. |
|
| August 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-35647 LIFEVANTAGE CORPORATIO |
|
| August 28, 2024 |
Exhibit 21.1 SUBSIDIARIES OF LIFEVANTAGE CORPORATION Set forth below is a list of all subsidiaries of LifeVantage Corporation, a Delaware corporation, and the state or country of incorporation of each as of June 30, 2024. Name State or Country of Incorporation Dinng Creative, Inc. Utah Importadora LifeVantage S. de R.L. de C.V. Mexico LFVN Malaysia SDN. BHD. Malaysia LifeLine Nutraceuticals Corpor |
|
| August 28, 2024 |
Form of Key Executive Benefits Agreement 1 KEY EXECUTIVE BENEFITS AGREEMENT LifeVantage Corporation (the “Company”) has established this Key Executive Benefits Agreement (the “Agreement”) to attract, motivate and retain certain key executives of the Company. |
|
| August 28, 2024 |
As filed with the Securities and Exchange Commission on August [28], 2024 As filed with the Securities and Exchange Commission on August [28], 2024 Registration No. |
|
| August 28, 2024 |
Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) LifeVantage Corporation (Exact name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule(4) Amount Registered(1) Proposed Maximum Offering Price Per Share Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee(4) Equity Common Stock, par value $0. |
|
| August 26, 2024 |
LifeVantage Welcomes Rajendran Anbalagan to the Board of Directors; Thanks Erin Brockovich for Her Years of Service SALT LAKE CITY, August 26, 2024 - LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, announced the appointment of Rajendran Anbalagan to the Company’s Board of Directors effective today. |
|
| August 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 26, 2024 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organizat |
|
| July 31, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 4)1 LifeVantage Corporation (Name of Issuer) Common Stock, par value $0.0001 (Title of Class of Securities) 53222K205 (CUSIP Number) BRADLEY L. RADOFF 2727 |
|
| May 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission file number 001-35647 LIFEVANTAGE CORPORATION (Exa |
|
| May 2, 2024 |
LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2024 LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2024 Salt Lake City, UT, May 2, 2024, LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its third fiscal quarter ended March 31, 2024. |
|
| May 2, 2024 |
evolvecompensationplanuk Evolve COMPENSATION PLAN GUIDE FOR INDEPENDENT LIFEVANTAGE CONSULTANTS UNITED KINGDOM Effective February 1, 2024 activatedLife. |
|
| May 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 2, 2024 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organization) |
|
| May 2, 2024 |
Evolve COMPENSATION PLAN GUIDE FOR INDEPENDENT LIFEVANTAGE CONSULTANTS EUROPE Effective February 1, 2024 activatedLife. |
|
| May 2, 2024 |
Evolve Compensation Plan (Mexico) evolvecompensationplanme Evolve GUÍA DEL PLAN DE COMPENSACIÓN PARA CONSULTORES INDEPENDIENTES DE LIFEVANTAGE MÉXICO Válido a partir del 1° de febrero de 2024 activadaLa vida. |
|
| May 2, 2024 |
Evolve Compensation Plan (Canada) evolvecompensationplanca Evolve COMPENSATION PLAN GUIDE FOR INDEPENDENT LIFEVANTAGE CONSULTANTS CANADA Effective February 1, 2024 activatedLife. |
|
| April 16, 2024 |
, as Borrower, Lifeline Nutraceuticals Corporation, as Guarantor, and Bank of America, N.A. ACTIVE 696107325v8 SECURITY AND PLEDGE AGREEMENT THIS SECURITY AND PLEDGE AGREEMENT (this “Agreement”) is entered into as of April 12, 2024 among LIFEVANTAGE CORPORATION, a Delaware corporation (the “Borrower”), LIFELINE NUTRACEUTICALS CORPORATION, a Colorado corporation (the “Guarantor”), and such other parties that may become Grantors hereunder after the date hereof (together with the Borrower and the Guarantor, each individually a “Grantor”, and collectively, the “Grantors”), and BANK OF AMERICA, N. |
|
| April 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 12, 2024 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organizati |
|
| April 16, 2024 |
ACTIVE 696107200v6 BORROWER: LifeVantage Corporation GUARANTOR: Lifeline Nutraceuticals Corporation CONTINUING AND UNCONDITIONAL GUARANTY 1. |
|
| April 16, 2024 |
ACTIVE 696074304v9 LOAN AGREEMENT This Loan Agreement (this “Agreement”), dated as of April 12, 2024, is between Bank of America, N. |
|
| February 15, 2024 |
SC 13D/A 1 sc13da30907605702152024.htm AMENDMENT NO. 3 TO THE SCHEDULE 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 3)1 LifeVantage Corporation (Name of Issuer) Common Stock, par value $0.0001 (Ti |
|
| February 15, 2024 |
Exhibit 99.2 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of Common Stock, par value $0.0001, of LifeVantage Corporation, a Delaware corporation. This |
|
| February 15, 2024 |
LifeVantage Appoints Dayton Judd to the Board of Directors Enters into Cooperation Agreement with the Radoff-Sudbury Group Salt Lake City, UT, February 15, 2024 (GLOBE NEWSWIRE) - LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the appointment of Dayton Judd to the Company’s Board of Directors (the “Board”), effective immediately, in an expansion of the Board. |
|
| February 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 14, 2024 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organiz |
|
| February 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 3)1 LifeVantage Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 53222K205 (CUSIP Number) Dayton Judd |
|
| February 15, 2024 |
Execution Version 1 COOPERATION AGREEMENT This Cooperation Agreement (this “Agreement”), effective as of February 14, 2024 (the “Effective Date”), is entered into by and among LifeVantage Corporation, a Delaware corporation (the “Company”), the entities and persons listed on Exhibit A hereto (collectively, the “Radoff Parties”) and the entities and persons listed on Exhibit B hereto (collectively, the “Sudbury Parties” and together with the Radoff Parties, the “Stockholder Parties” and each, a “Stockholder Party”). |
|
| February 15, 2024 |
EX-99.2 2 ex992to13da309076057021524.htm JOINT FILING AGREEMENT Exhibit 99.2 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of Common Stock, par value $ |
|
| January 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission file number 001-35647 LIFEVANTAGE CORPORATION ( |
|
| January 30, 2024 |
LifeVantage Announces Financial Results for the Second Quarter of Fiscal 2024 LifeVantage Announces Financial Results for the Second Quarter of Fiscal 2024 Salt Lake City, UT, January 30, 2024, LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its second fiscal quarter ended December 31, 2023. |
|
| January 30, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 30, 2024 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organiza |
|
| November 14, 2023 |
EX-99.1 2 ex991to13da209076057111423.htm GROUP AGREEMENT Exhibit 99.1 GROUP AGREEMENT This Agreement (this “Agreement”) is made and entered into as of November 10, 2023 by and among (i) Bradley L. Radoff and The Radoff Family Foundation (collectively, “Radoff”), and (ii) Dayton Judd, Sudbury Capital Fund, LP, Sudbury Holdings, LLC, Sudbury Capital GP, LP and Sudbury Capital Management, LLC (collec |
|
| November 14, 2023 |
EX-99.2 3 ex992to13da209076057111423.htm DOCUMENT PRESERVATION NOTICE Exhibit 99.2 O L S H A N 1325 AVENUE OF THE AMERICAS ● NEW YORK, NEW YORK 10019 TELEPHONE: 212.451.2300 ● FACSIMILE: 212.451.2222 EMAIL: [email protected] DIRECT DIAL: 212.451.2257 November 13, 2023 By Email LifeVantage Corporation 3300 North Triumph Boulevard, Suite 700 Lehi, Utah 84043 Attn: Alissa Neufeld General C |
|
| November 14, 2023 |
EX-99.2 3 ex992to13da209076057111423.htm DOCUMENT PRESERVATION NOTICE Exhibit 99.2 O L S H A N 1325 AVENUE OF THE AMERICAS ● NEW YORK, NEW YORK 10019 TELEPHONE: 212.451.2300 ● FACSIMILE: 212.451.2222 EMAIL: [email protected] DIRECT DIAL: 212.451.2257 November 13, 2023 By Email LifeVantage Corporation 3300 North Triumph Boulevard, Suite 700 Lehi, Utah 84043 Attn: Alissa Neufeld General C |
|
| November 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 2)1 LifeVantage Corporation (Name of Issuer) Common Stock, par value $0.0001 (Title of Class of Securities) 53222K205 (CUSIP Number) BRADLEY L. RADOFF 2727 |
|
| November 14, 2023 |
SC 13D/A 1 sc13da21390000211142023.htm AMENDMENT NO. 2 TO THE SCHEDULE 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 2)1 LifeVantage Corporation (Name of Issuer) Common Stock, par value $0.0001 per |
|
| November 14, 2023 |
EX-99.1 2 ex991to13da209076057111423.htm GROUP AGREEMENT Exhibit 99.1 GROUP AGREEMENT This Agreement (this “Agreement”) is made and entered into as of November 10, 2023 by and among (i) Bradley L. Radoff and The Radoff Family Foundation (collectively, “Radoff”), and (ii) Dayton Judd, Sudbury Capital Fund, LP, Sudbury Holdings, LLC, Sudbury Capital GP, LP and Sudbury Capital Management, LLC (collec |
|
| November 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2023 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organi |
|
| November 13, 2023 |
lfvnproxyfightoutcomepre Stockholders Re-Elect All Seven LifeVantage Incumbent Directors at Fiscal Year 2024 Annual Meeting Salt Lake City, UT, November 13, 2023 (GLOBE NEWSWIRE) - LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company”), a leading health and wellness company with products designed to activate optimal health processes, today announced the final, certified results of its fiscal year 2024 annual meeting of stockholders (the “Annual Meeting”), as provided to the Company by the independent inspector of elections. |
|
| November 9, 2023 |
between Sumitomo Mitsui Trust Bank, Limited and LifeVantage Japan Lease Agreement May 26, 2023 Lessor Sumitomo Mitsui Trust Bank, Limited Lessee LifeVantage Japan Corporation Summary of Terms (1) Lease Property Description of Building Location: 2- 16-4 Konan, Minato-ku, Tokyo Building Name: Shinagawa Grand Central Tower (2) Purpose of Use/ Type of Business Purpose of Use: offices Type of Business: Import, manufacture and sale of health foods and nutritional supplements, cosmetics and quasi-medical products, daily necessities, etc. |
|
| November 9, 2023 |
LifeVantage Announces Financial Results for the First Quarter of Fiscal 2024 LifeVantage Announces Financial Results for the First Quarter of Fiscal 2024 Salt Lake City, UT, November 9, 2023, LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes, today reported financial results for its first fiscal quarter ended September 30, 2023. |
|
| November 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission file number 001-35647 LIFEVANTAGE CORPORATION |
|
| November 9, 2023 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2023 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organiza |
|
| November 9, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2023 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organiza |
|
| November 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| October 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| October 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| October 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| October 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| October 25, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| October 25, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| October 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| October 18, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| October 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| October 16, 2023 |
EXHIBIT 1 - INVESTOR PRESENTATION OCTOBER 2023 Executing on Our Transformation to Drive Stockholder ValueI N V E S T O R P R E S E N T A T I ON What Is This Proxy Contest About? 2 This proxy contest is about whether half of the independent directors of LifeVantage – nearly all of the Board’s leadership – should be replaced despite the Board’s proactive reformation of the Company’s management team and strategy that has led LifeVant |
|
| October 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| October 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| October 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| October 12, 2023 |
EXHIBIT 1 - INVESTOR PRESENTATION 9MJ(FXJKTW'TFWIWTTR (MFSLJFY1NKJ;FSYFLJ 5WJUFWJIG^YMJ7FITKK8ZIGZW^,WTZU 4HYTGJW7FITKK8ZIGZW^,WTZU 1JLFQ)NXHQFNRJW 9MJRFYJWNFQXHTSYFNSJIMJWJNS YMJѦ2FYJWNFQXѧWJUWJXJSYYMJ TUNSNTSXTK'WFIQJ^17FITKK8ZIGZW^(FUNYFQ+ZSI15FSIYMJ TYMJWUFWYNHNUFSYXSFRJINSYMJUWT]^XTQNHNYFYNTS HTQQJHYN[J Q^YMJѦ7FITKK 8ZIGZW^,WTZUѧѦ\JѧTWTZWѦ,WTZUѧFSIFWJGFXJITSUZGQ |
|
| October 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| October 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| October 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| October 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| October 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| September 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| September 26, 2023 |
ÊÑÌÛ ÌØÛ ÞÔËÛ ÐÎÑÈÇ ÝßÎÜ Ú»´´±© ͬ±½µ¸±´¼»®ô ̸» ο¼±ººóÍ«¼¾«®§ Ù®±«° ±©² ¿°°®±¨·³¿¬»´§ ïîòèû ±º Ô·º»Ê¿²¬¿¹»ô ·¹²¿´·²¹ ±«® ¬®±²¹ ¿´·¹²³»²¬ ©·¬¸ §±«® ·²¬»®»¬ ¿²¼ ¿´´ ݱ³°¿²§ ¬¿µ»¸±´¼»®ò É» ¾»´·»ª» ¬¸¿¬ Ô·º»Ê¿²¬¿¹» ¸»¿´¬¸ °®±¼«½¬ô ¿´» ³±¼»´ ¿²¼ ¹®±©¬¸ ¬®¿¬»¹§ ¸¿ª» ¬¸» °±¬»²¬·¿´ ¬± ½®»¿¬» ·¹²·º·½¿²¬ ª¿´«» ±ª»® ¬¸» ´±²¹ó¬»®³ò λ¹®»¬¬¿¾´§ô ¬¸· °±¬»²¬·¿´ ¸¿ ¾»»² ¸·²¼»®»¼ ±ª»® ¬¸» °¿¬ ¼»½¿¼» ¾§ ݸ¿·®³¿² |
|
| September 25, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| September 25, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of |
|
| September 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ý Defin |
|
| September 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confide |
|
| September 8, 2023 |
PRELIMINARY PROXY STATEMENT SUBJECT TO COMPLETION — DATED SEPTEMBER 8, 2023 PRELIMINARY PROXY STATEMENT SUBJECT TO COMPLETION — DATED SEPTEMBER 8, 2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| August 31, 2023 |
LIFEVANTAGE CORPORATION and COMPUTERSHARE TRUST COMPANY, N.A., as Rights Agent RIGHTS AGREEMENT Dated as of August 30, 2023 TABLE OF CONTENTS Page Section 1. Certain Definitions ................................................................................................ 1 Section 2. Appointment of Rights Agent ............................................................................... 8 Se |
|
| August 31, 2023 |
LIFEVANTAGE CORPORATION and COMPUTERSHARE TRUST COMPANY, N.A., as Rights Agent RIGHTS AGREEMENT Dated as of August 30, 2023 TABLE OF CONTENTS Page Section 1. Certain Definitions ................................................................................................ 1 Section 2. Appointment of Rights Agent ............................................................................... 8 Se |
|
| August 31, 2023 |
CERTIFICATE OF DESIGNATION of SERIES A JUNIOR PARTICIPATING PREFERRED STOCK of LIFEVANTAGE CORPORATION Pursuant to Section 151 of the General Corporation Law of the State of Delaware LifeVantage Corporation, a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), in accordance with the provisions of Section 103 thereof, DOES HEREBY CERTIFY: That pursuant t |
|
| August 31, 2023 |
Certificate of Designation of Series A Junior Participating Preferred Stock of Registrant CERTIFICATE OF DESIGNATION of SERIES A JUNIOR PARTICIPATING PREFERRED STOCK of LIFEVANTAGE CORPORATION Pursuant to Section 151 of the General Corporation Law of the State of Delaware LifeVantage Corporation, a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), in accordance with the provisions of Section 103 thereof, DOES HEREBY CERTIFY: That pursuant t |
|
| August 31, 2023 |
LifeVantage Adopts Limited Duration Stockholder Rights Plan Salt Lake City, UT, August 31, 2023, (GLOBE NEWSWIRE) - LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company”), a leading health and wellness company with products designed to activate optimal health processes, today announced that its Board of Directors (the “Board”) has adopted a limited duration stockholder rights plan (the “Rights Plan”). |
|
| August 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 30, 2023 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organizat |
|
| August 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 90-0224471 (State or other jurisdiction of incorporation) (IRS Employer Identification Number) 3300 Triumph B |
|
| August 28, 2023 |
Evolve Compensation Plan (Japan) in US/English Format Evolve COMPENSATION PLAN GUIDE FOR INDEPENDENT LIFEVANTAGE CONSULTANTS JAPAN Effective March 1, 2023 activatedLife. |
|
| August 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the fiscal year ended June 30, 2023 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from to Commission file number: 001-35647 LIFEVANTAGE CORPORATION (Exact |
|
| August 28, 2023 |
Amended and Restated LifeVantage Corporation 2017 Long-Term Incentive Plan 1 LIFEVANTAGE CORPORATION 2017 LONG-TERM INCENTIVE PLAN (Adopted on December 6, 2016, Effective on February 16, 2017 and Amended on November 16, 2017, January 19, 2018, September 20, 2018, August 27, 2020 and September 19, 2022) SECTION 1. |
|
| August 28, 2023 |
Evolve Compensation Plan (New Zealand) Evolve COMPENSATION PLAN GUIDE FOR INDEPENDENT LIFEVANTAGE CONSULTANTS NEW ZEALAND Effective March 20, 2023 activatedLife. |
|
| August 28, 2023 |
LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2023 Declares Special Cash Dividend of $0. |
|
| August 28, 2023 |
Evolve Compensation Plan (United States) Evolve COMPENSATION PLAN GUIDE FOR INDEPENDENT LIFEVANTAGE CONSULTANTS USA E!ective March 13, 2023 Welcome 2 activatedLife. |
|
| August 28, 2023 |
Form of Key Executive Benefits A 1 KEY EXECUTIVE BENEFITS AGREEMENT LifeVantage Corporation (the “Company”) has established this Key Executive Benefits Agreement (the “Agreement”) to attract, motivate and retain certain key executives of the Company. |
|
| August 28, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 28, 2023 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organizat |
|
| August 28, 2023 |
Evolve Compensation Plan (Australia) Evolve COMPENSATION PLAN GUIDE FOR INDEPENDENT LIFEVANTAGE CONSULTANTS AUSTRALIA Effective March 20, 2023 activatedLife. |
|
| August 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2023 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organizati |
|
| August 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Def |
|
| August 11, 2023 |
Exhibit 99.2 POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints Bradley L. Radoff the undersigned’s true and lawful attorney-in-fact to take any and all action in connection with (i) the undersigned’s beneficial ownership of, or participation in a group with respect to, securities of LifeVantage Corporation, a Delaware corporation (the “Company”), di |
|
| August 11, 2023 |
JOINT FILING AND SOLICITATION AGREEMENT Exhibit 99.1 JOINT FILING AND SOLICITATION AGREEMENT This Agreement (this “Agreement”) is made and entered into as of August 9, 2023 by and among (i) Bradley L. Radoff and The Radoff Family Foundation (collectively, “Radoff”), (ii) Dayton Judd, Sudbury Capital Fund, LP, Sudbury Holdings, LLC, Sudbury Capital GP, LP and Sudbury Capital Management, LLC (collectively, “Sudbury”) and (iii) Michael Loh |
|
| August 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 1)1 LifeVantage Corporation (Name of Issuer) Common Stock, par value $0.0001 (Title of Class of Securities) 53222K205 (CUSIP Number) BRADLEY L. RADOFF 2727 |
|
| August 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 1)1 LifeVantage Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 53222K205 (CUSIP Number) Dayton Judd |
|
| August 11, 2023 |
JOINT FILING AND SOLICITATION AGREEMENT Exhibit 99.1 JOINT FILING AND SOLICITATION AGREEMENT This Agreement (this “Agreement”) is made and entered into as of August 9, 2023 by and among (i) Bradley L. Radoff and The Radoff Family Foundation (collectively, “Radoff”), (ii) Dayton Judd, Sudbury Capital Fund, LP, Sudbury Holdings, LLC, Sudbury Capital GP, LP and Sudbury Capital Management, LLC (collectively, “Sudbury”) and (iii) Michael Loh |
|
| June 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 12, 2023 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organizatio |
|
| June 13, 2023 |
lfvn-pressreleasexannoun LifeVantage Extends Stock Repurchase Program Salt Lake City, UT, June 13, 2023, (GLOBE NEWSWIRE) - LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes, today announced that the Company’s Board of Directors has approved an extension to the previously authorized stock repurchase program extending it until December 31, 2026. |
|
| May 15, 2023 |
LFVN / Lifevantage Corporation / Radoff Bradley Louis - THE SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. )1 LifeVantage Corporation (Name of Issuer) Common Stock, par value $0.0001 (Title of Class of Securities) 53222K205 (CUSIP Number) BRADLEY L. RADOFF 2727 |
|
| May 15, 2023 |
Exhibit 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of Common Stock, par value $0.0001, of LifeVantage Corporation, a Delaware corporation. This |
|
| May 4, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission file number 001-35647 LIFEVANTAGE CORPORATION (Exa |
|
| May 4, 2023 |
LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2023 LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2023 Salt Lake City, UT, May 4, 2023, LifeVantage Corporation (Nasdaq: LFVN) today reported financial results for its third fiscal quarter ended March 31, 2023. |
|
| May 4, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2023 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organization) |
|
| April 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 13, 2023 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organizati |
|
| April 4, 2023 |
April 4, 2023 VIA EDGAR Division of Corporation Finance Office of Life Sciences United States Securities and Exchange Commission 100 F Street, N. |
|
| March 31, 2023 |
Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) LifeVantage Corporation (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Security Type Security Class Title (1) Fee Calculation Rule Amount Registered (2) Proposed Maximum Offering Price Per Unit (2) Maximum Aggregate Offering Price (2) Fee Rate Amount of Registration Fee Equity Common stock, $0. |
|
| March 31, 2023 |
As filed with the Securities and Exchange Commission on March 31, 2023 Registration No. |
|
| March 31, 2023 |
Form of Indenture with respect to the Securities. EX-4.4 3 ex44indentureform2023s-3.htm EX-4.4 Exhibit 4.4 INDENTURE between LIFEVANTAGE CORPORATION as Issuer and [TRUSTEE] as Trustee Dated as of , 20 Providing for the Issuance of Debt Securities in Series LIFEVANTAGE CORPORATION Reconciliation and tie between the Trust Indenture Act of 1939 and the Indenture Trust Indenture Act Section Indenture Section Sec. 310(a)(1) 607 (a)(2) 607 (b) 608 Sec. |
|
| March 23, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 20, 2023 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organizati |
|
| February 16, 2023 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 15, 2023 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organiz |
|
| February 16, 2023 |
Letter to the Securities and Exchange Commission from WSRP, LLC, dated February 16, 2023 GDSVF&H\8762231.1 Exhibit 16.1 February 16, 2023 Securities and Exchange Commission 100 F Street N.E. Washington, D.C. 20549 We have been furnished with a copy of the response to Item 4.01 of Form 8-K dated February 16, 2023. We agree with the statements made in response to that Item insofar as they relate to our Firm. Very truly yours, /s/ WSRP, LLC WSRP, LLC |
|
| February 9, 2023 |
LFVN / LifeVantage Corp / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv01308-lifevantagecorp.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 2)* Name of issuer: Lifevantage Corp. Title of Class of Securities: Common Stock CUSIP Number: 53222K205 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate |
|
| February 2, 2023 |
LifeVantage Announces Financial Results for the Second Quarter of Fiscal 2023 LifeVantage Announces Financial Results for the Second Quarter of Fiscal 2023 Salt Lake City, UT, February 2, 2023, LifeVantage Corporation (Nasdaq: LFVN) today reported financial results for its second fiscal quarter ended December 31, 2022. |
|
| February 2, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 2, 2023 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organiza |
|
| February 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission file number 001-35647 LIFEVANTAGE CORPORATION ( |
|
| January 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 18, 2023 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organiza |
|
| November 18, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 10, 2022 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organ |
|
| November 17, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 10, 2022 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organiz |
|
| November 2, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2022 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organiza |
|
| November 2, 2022 | ||
| November 2, 2022 |
LifeVantage Announces Financial Results for the First Quarter of Fiscal 2023 LifeVantage Announces Financial Results for the First Quarter of Fiscal 2023 Salt Lake City, UT, November 2, 2022, LifeVantage Corporation (Nasdaq: LFVN) today reported financial results for its first fiscal quarter ended September 30, 2022. |
|
| November 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ? QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission file number 001-35647 LIFEVANTAGE CORPORATION |
|
| September 30, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Prox |
|
| September 30, 2022 |
DEF 14A 1 proxystatementfy2023.htm DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only |
|
| September 6, 2022 |
LFVN / LifeVantage Corp / Sudbury Capital Fund, LP - SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 LIVEVANTAGE CORPORATION (Name of Issuer) Common Stock, Par Value $0.0001 Per Share (Title of Class of Securities) 53222K205 (CUSIP Number) Dayton Judd Sudbury Capital Fund, LP 136 Oak Trail Coppell, TX 75019 972-304-5000 (Name, Address and Telephone Number of Person Author |
|
| August 23, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 23, 2022 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organizat |
|
| August 23, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the fiscal year ended June 30, 2022 ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from to Commission file number: 001-35647 LIFEVANTAGE CORPORATION (Exact |
|
| August 23, 2022 |
Amended and Restated LifeVantage Corporation 2017 Long-Term Incentive Plan 1 LIFEVANTAGE CORPORATION 2017 LONG-TERM INCENTIVE PLAN (Adopted on December 6, 2016, Effective on February 16, 2017 and Amended on November 16, 2017, January 19, 2018, September 20, 2018, and August 27, 2020) SECTION 1. |
|
| August 23, 2022 |
EX-4.2 2 ex42descriptionofcapitalst.htm EX-4.2 Exhibit 4.2 DESCRIPTION OF CAPITAL STOCK General LifeVantage Corporation (“we,” “us,” and “our”) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended - our common stock, $0.0001 par value per share. The following information describes our capital stock, as well as certain provisions of our certific |
|
| August 23, 2022 |
Code of Business Conduct and Ethics Message from the President & CEO This year has been a very different one both globally and at LifeVantage. |
|
| August 23, 2022 |
LifeVantage Sales Compensation Plan SALES COMPENSATION PLAN HIGHLIGHTS ? UNITED STATES OF AMERICA (1) EFFECTIVE MAY 5, 2020 *PV = Product Volume. |
|
| August 23, 2022 |
LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2022 LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2022 Salt Lake City, UT, August 23, 2022, LifeVantage Corporation (Nasdaq: LFVN) today reported financial results for its fourth quarter and full fiscal year ended June 30, 2022. |
|
| August 23, 2022 |
Forms of Key Executive Benefits Package -1- KEY EXECUTIVE BENEFIT PACKAGE LifeVantage has established this Key Executive Benefit Package to attract, motivate and retain certain key executives of the company. |
|
| August 23, 2022 |
Exhibit 21.1 SUBSIDIARIES OF LIFEVANTAGE CORPORATION Set forth below is a list of all subsidiaries of LifeVantage Corporation, a Delaware corporation, and the state or country of incorporation of each as of June 30, 2021. Name State or Country of Incorporation Dinng Creative, Inc. Utah Importadora LifeVantage S. de R.L. de C.V. Mexico LFVN Malaysia SDN. BHD. Malaysia LifeLine Nutraceuticals Corpor |
|
| May 3, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2022 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organization) |
|
| May 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ? QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission file number 001-35647 LIFEVANTAGE CORPORATION (Exa |
|
| May 3, 2022 |
LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2022 Initiates first quarterly dividend of $0. |
|
| March 11, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 7, 2022 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organizatio |
|
| February 17, 2022 |
LifeVantage Appoints Cindy Latham to Board of Directors LifeVantage Appoints Cindy Latham to Board of Directors Salt Lake City, UT, February 17, 2022, (GLOBE NEWSWIRE) - LifeVantage Corporation (Nasdaq:LFVN) today announced the appointment of Cindy Latham to the Company's Board of Directors. |
|
| February 17, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 17, 2022 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organiz |
|
| February 10, 2022 |
LFVN / LifeVantage Corp / VANGUARD INDEX FUNDS - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1)* Name of issuer: Lifevantage Corp. Title of Class of Securities: Common Stock CUSIP Number: 53222K205 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ R |
|
| February 10, 2022 |
LFVN / LifeVantage Corp / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1)* Name of issuer: Lifevantage Corp. Title of Class of Securities: Common Stock CUSIP Number: 53222K205 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ R |
|
| February 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ? QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission file number 001-35647 LIFEVANTAGE CORPORATION ( |
|
| February 1, 2022 |
LifeVantage Announces Financial Results for the Second Quarter of Fiscal 2022 LifeVantage Announces Financial Results for the Second Quarter of Fiscal 2022 Salt Lake City, UT, February 1, 2022, LifeVantage Corporation (Nasdaq: LFVN) today reported financial results for its second fiscal quarter ended December 31, 2021. |
|
| February 1, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 1, 2022 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organiza |
|
| November 15, 2021 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 11, 2021 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organiz |
|
| November 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ? QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission file number 001-35647 LIFEVANTAGE CORPORATION |
|
| November 4, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 4, 2021 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organiza |
|
| November 4, 2021 |
LifeVantage Announces Financial Results for the First Quarter of Fiscal 2022 Revenue of $53. |
|
| October 25, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 25, 2021 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organiza |
|
| October 25, 2021 |
Key Employee Benefits Package by and between EX-10.2 3 lfvnkeyexecutivebenefit.htm EX-10.2 -1- KEY EXECUTIVE BENEFIT PACKAGE LifeVantage has established this Key Executive Benefit Package to attract, motivate and retain certain key executives of the company. An employee is considered a Key Executive upon the recommendation of the CEO and approval by the Company's Compensation Committee. The components of the Key Executive Benefit Package are |
|
| October 25, 2021 |
LifeVantage Appoints Carl Aure as Chief Financial Officer LifeVantage Appoints Carl Aure as Chief Financial Officer Salt Lake City, UT, October 25, 2021, (GLOBE NEWSWIRE) - LifeVantage Corporation (Nasdaq:LFVN) today announced the appointment of Carl Aure as Chief Financial Officer. |
|
| October 25, 2021 |
September 17, 2021 Carl Aure [email protected] Dear Carl, LifeVantage Corporation (the ?Company?), is pleased to offer you a position as Chief Financial Officer reporting directly to our President & CEO. We trust that your knowledge, skills and experience will be among our most valuable assets. ? Salary: Annual gross starting salary of $350,000 paid in installments by direct deposit. ? Performance |
|
| September 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| September 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Prox |
|
| August 19, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the fiscal year ended June 30, 2021 ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from to Commission file number: 001-35647 LIFEVANTAGE CORPORATION (Exact |
|
| August 19, 2021 |
Exhibit 4.2 DESCRIPTION OF CAPITAL STOCK General LifeVantage Corporation (?we,? ?us,? and ?our?) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended - our common stock, $0.0001 par value per share. The following information describes our capital stock, as well as certain provisions of our certificate of incorporation and amended and restated b |
|
| August 19, 2021 |
SALES COMPENSATION PLAN HIGHLIGHTS ? UNITED STATES OF AMERICA (1) EFFECTIVE MAY 5, 2020 *PV = Product Volume. |
|
| August 19, 2021 |
Form of Key Executive Benefits Package -1- KEY EXECUTIVE BENEFIT PACKAGE LifeVantage has established this Key Executive Benefit Package to attract, motivate and retain certain key executives of the company. |
|
| August 19, 2021 |
Exhibit 21.1 SUBSIDIARIES OF LIFEVANTAGE CORPORATION Set forth below is a list of all subsidiaries of LifeVantage Corporation, a Delaware corporation, and the state or country of incorporation of each as of June 30, 2021. Name State or Country of Incorporation Dinng Creative, Inc. Utah Importadora LifeVantage S. de R.L. de C.V. Mexico LFVN Malaysia SDN. BHD. Malaysia LifeLine Nutraceuticals Corpor |
|
| August 19, 2021 |
Amended and Restated LifeVantage Corporation 2017 Long-Term Incentive Plan 1 LIFEVANTAGE CORPORATION 2017 LONG-TERM INCENTIVE PLAN (Adopted on December 6, 2016, Effective on February 16, 2017 and Amended on November 16, 2017, January 19, 2018, September 20, 2018, and August 27, 2020) SECTION 1. |
|
| August 19, 2021 |
Code of Business Conduct and Ethics Message from the President & CEO This year has been a very different one both globally and at LifeVantage. |
|
| August 19, 2021 |
LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2021 Revenue of $220 million for Fiscal 2021 Fourth Quarter Adjusted EPS Increased 10. |
|
| August 19, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 19, 2021 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organizat |
|
| August 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 12, 2021 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organizat |
|
| May 26, 2021 |
Key Employee Benefits Package by and between Matthew Cooley and LifeVantage Corporation dated May - Doc ID: 05e1880a12776c9b7a68d56db4d8c28a8b7a524d - Doc ID: 05e1880a12776c9b7a68d56db4d8c28a8b7a524d - Doc ID: 05e1880a12776c9b7a68d56db4d8c28a8b7a524d - Doc ID: 05e1880a12776c9b7a68d56db4d8c28a8b7a524d - Doc ID: 05e1880a12776c9b7a68d56db4d8c28a8b7a524d - Doc ID: 05e1880a12776c9b7a68d56db4d8c28a8b7a524d - Doc ID: 05e1880a12776c9b7a68d56db4d8c28a8b7a524d - Doc ID: 05e1880a12776c9b7a68d56db4d8c28a8b7a524d - 04 / 29 / 2021 04 / 29 / 2021 Doc ID: 05e1880a12776c9b7a68d56db4d8c28a8b7a524d - Doc ID: 05e1880a12776c9b7a68d56db4d8c28a8b7a524d Audit Trail Title File Name Document ID Audit Trail Date Format Status Key Executive Benefits Agreement Key Executive Benefits Agreement. |
|
| May 26, 2021 |
Offer Letter by and between Matthew Cooley and LifeVantage Corporation dated May ? ? ? ? ? ? ? ? ? ? ? ? 04 / 29 / 2021 Doc ID: c8117190435e8a587a7e8b09a26040a20f396f62 Audit Trail Title File Name Document ID Audit Trail Date Format Status Offer Letter Offer Letter. |
|
| May 26, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 20, 2021 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organization |
|
| April 29, 2021 |
CEO Offer Letter between the Company and Steven R. Fife dated January 31, 2021 GDSVF&H\5569755.1 LIFEVANTAGE CORPORATION 3300 TRIUMPH BLVD LEHI, UTAH 84043 January 31, 2021 Steven R. Fife Dear Steve, LifeVantage Corporation (the ?Company?) is pleased to offer you the role of President and Chief Executive Officer of the Company on the following terms: 1. Position. Your title will be President and Chief Executive Officer. Until a new Chief Financial Officer is appointed, you w |
|
| April 29, 2021 |
EX-10.2 3 sfifeexecutivebenefitspa.htm EX-10.2 GDSVF&H\5569757.3 AMENDED AND RESTATED KEY EXECUTIVE BENEFIT PACKAGE LifeVantage has established this Key Executive Benefit Package to attract, motivate and retain certain key executives of the company. You are considered a Key Executive upon execution of this agreement. The components of the Key Executive Benefit Package are included below. 1. Positi |
|
| April 29, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 29, 2021 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organizati |
|
| April 29, 2021 |
LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2021 Revenue of $51. |
|
| April 29, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ? QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission file number 001-35647 LIFEVANTAGE CORPORATION (Exa |
|
| April 29, 2021 |
Change in Terms Agreement dated April 1, 2021 by and between Zions Bank and the Company |
|
| February 10, 2021 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 Name of issuer: Lifevantage Corp. Title of Class of Securities: Common Stock CUSIP Number: 53222K205 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 13d-1(b) ☐ Rule |
|
| February 8, 2021 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 Name of issuer: Lifevantage Corp. Title of Class of Securities: Common Stock CUSIP Number: 53222K205 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 13d-1(b) ☐ Rule |
|
| February 2, 2021 |
EX-99.2 3 exhibit992pressrelease.htm EX-99.2 LifeVantage Announces Appointment of Chief Executive Officer Steven R. Fife Named President, CEO & Director Salt Lake City, UT, February 2, 2021, (GLOBE NEWSWIRE) - LifeVantage Corporation (Nasdaq:LFVN) announced today that its Board of Directors has named Steven Fife as President and Chief Executive Officer. Mr. Fife’s appointment is effective immediat |
|
| February 2, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 1, 2021 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organiza |
|
| February 2, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission file number 001-35647 LIFEVANTAGE CORPORATION ( |
|
| February 2, 2021 |
LifeVantage Announces Financial Results for the Second Quarter of Fiscal 2021 Revenue of $59. |
|
| January 11, 2021 |
As filed with the Securities and Exchange Commission on January 11, 2021 Registration No. |
|
| November 17, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 12, 2020 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organiz |
|
| November 17, 2020 |
LifeVantage Corporation 2017 Long-Term Incentive Plan, as amended. EX-10.1 2 a2017ltip.htm EX-10.1 LIFEVANTAGE CORPORATION 2017 LONG-TERM INCENTIVE PLAN (Adopted on December 6, 2016, Effective on February 16, 2017 and Amended on November 16, 2017, January 19, 2018, September 20, 2018, and August 27, 2020) SECTION 1. INTRODUCTION The Board adopted the LifeVantage Corporation 2017 Long-Term Incentive Plan on the Adoption Date conditioned upon and subject to obtaini |
|
| November 4, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Defin |
|
| November 3, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 3, 2020 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organiza |
|
| November 3, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission file number 001-35647 LIFEVANTAGE CORPORATION |
|
| November 3, 2020 |
LifeVantage Announces Financial Results for the First Quarter of Fiscal 2021 First Quarter Adjusted EPS and Adjusted EBITDA Increased 92% and 43%, respectively Reiterates Guidance Salt Lake City, UT, November 3, 2020, LifeVantage Corporation (Nasdaq: LFVN) today reported financial results for its first quarter ended September 30, 2020. |
|
| September 30, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ý Defin |
|
| September 30, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Defin |
|
| September 8, 2020 |
Separation Agreement, dated September 4, 2020, by and between the Company and SEPARATION AGREEMENT AND GENERAL RELEASE This Separation Agreement and General Release (“Agreement”) is entered into by and between Darren Jensen (“Employee”) and LifeVantage Corporation, a Delaware corporation (the “Company” or “Employer”) (together the “Parties”) in consideration for and as condition precedent to Employer providing the separation benefits to Employee as set forth below. |
|
| September 8, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 3, 2020 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organiz |
|
| September 8, 2020 |
EX-99.1 3 exhibit991pressrelease.htm EX-99.1 LifeVantage Announces Management Transition Steven Fife Appointed Interim Chief Executive Officer Justin Rose to Lead Combined Sales & Marketing Team Reiterates Fiscal 2021 Guidance Salt Lake City, UT, September 8, 2020, (GLOBE NEWSWIRE) - LifeVantage Corporation (Nasdaq:LFVN) announced today that Darren Jensen, the Company's President and Chief Executi |
|
| August 18, 2020 |
LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2020 Record Fiscal 2020 Revenue of $233 million Fiscal 2020 Adjusted EBITDA Increased 31. |
|
| August 18, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 18, 2020 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organizat |
|
| August 18, 2020 |
Exhibit 21.1 SUBSIDIARIES OF LIFEVANTAGE CORPORATION Set forth below is a list of all subsidiaries of LifeVantage Corporation, a Delaware corporation, and the state or country of incorporation of each as of June 30, 2020. Name State or Country of Incorporation Dinng Creative, Inc. Utah Importadora LifeVantage S. de R.L. de C.V. Mexico LFVN Malaysia SDN. BHD. Malaysia LifeLine Nutraceuticals Corpor |
|
| August 18, 2020 |
Exhibit 4.2 DESCRIPTION OF CAPITAL STOCK General LifeVantage Corporation (“we,” “us,” and “our”) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended - our common stock, $0.0001 par value per share. The following information describes our capital stock, as well as certain provisions of our certificate of incorporation and amended and restated b |
|
| August 18, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the fiscal year ended June 30, 2020 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from to Commission file number: 001-35647 LIFEVANTAGE CORPORATION (Exact |
|
| May 5, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 5, 2020 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other Jurisdiction of Incorporation) (Commission Fil |
|
| May 5, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission file number 001-35647 LIFEVANTAGE CORPORATION (Exa |
|
| May 5, 2020 |
EX-99.1 2 earningsreleaseq3fy20.htm EX-99.1 LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2020 Third Quarter Revenue of $56 million Third Quarter Adjusted EBITDA Increased 26% Year over Year Reiterates Fiscal 2020 Adjusted Earnings Per Share and EBITDA Guidance Salt Lake City, UT, May 5, 2020, LifeVantage Corporation (Nasdaq: LFVN) today reported financial results for its |
|
| April 1, 2020 |
April 1, 2020 VIA EDGAR Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, N. |
|
| March 24, 2020 |
LFVN / Lifevantage Corp. S-3 - - S-3 As filed with the Securities and Exchange Commission on March 24, 2020 Registration No. |
|
| March 24, 2020 |
Form of Indenture with respect to the Securities. Exhibit 4.4 INDENTURE between LIFEVANTAGE CORPORATION as Issuer and [TRUSTEE] as Trustee Dated as of , 20 Providing for the Issuance of Debt Securities in Series LIFEVANTAGE CORPORATION Reconciliation and tie between the Trust Indenture Act of 1939 and the Indenture Trust Indenture Act Section Indenture Section Sec. 310(a)(1) 607 (a)(2) 607 (b) 608 Sec. 312(c) 701 Sec. 314(a) 703 (a)(4) 1004 (c)(1 |
|
| January 28, 2020 |
LEASE AGREEMENT LANDLORD: TRAVERSE RIDGE CENTER III LLC, a Utah limited liability company TENANT: LifeVantage Corporation, a Delaware corporation LEASE SUMMARY Traverse Ridge Center I 1. |
|
| January 28, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 28, 2020 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other Jurisdiction of Incorporation) (Commissio |
|
| January 28, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission file number 001-35647 LIFEVANTAGE CORPORATION ( |
|
| January 28, 2020 |
LifeVantage Announces Financial Results for the Second Quarter of Fiscal 2020 Record Second Quarter Revenue of $61 million, increased 5% year over year Second Quarter Adjusted EBITDA Increased 82% Reiterates Fiscal 2020 Guidance for Revenue and Adjusted EBITDA Raises Fiscal 2020 Adjusted EPS Guidance Salt Lake City, UT, January 28, 2020, LifeVantage Corporation (Nasdaq: LFVN) today reported financial results for its second quarter ended December 31, 2019. |
|
| January 14, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 9, 2020 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other Jurisdiction of Incorporation) (Commission |
|
| January 14, 2020 |
LifeVantage Posts Record Second Quarter Preliminary Revenue, Introduces Free Shipping in 2020 Preliminary revenue of approximately $61 million represents the highest quarterly revenue in company history LifeVantage to ring the Nasdaq closing bell today in celebration of “Wellness Week” LifeVantage to present at the 22nd ICR Conference Jan. |
|
| December 10, 2019 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 5, 2019 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other Jurisdiction of Incorporation) (Commissio |
|
| November 26, 2019 |
LFVN / Lifevantage Corp. DEFA14A - - DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Defin |
|
| October 30, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 30, 2019 LIFEVANTAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35647 90-0224471 (State or other Jurisdiction of Incorporation) (Commissio |
|
| October 30, 2019 |
EX-99.1 2 earningsreleaseq1fy20.htm EXHIBIT 99.1 LifeVantage Announces Financial Results for the First Quarter of Fiscal 2020 First Quarter Adjusted EPS and Adjusted EBITDA Increased 86% and 45%, respectively Strong initial sales following early Second Quarter launch of Protandim® NAD Synergizer Reiterates Fiscal 2020 Guidance for Revenue, Adjusted EBITDA and Adjusted EPS Salt Lake City, UT, Octob |
|
| October 30, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission file number 001-35647 LIFEVANTAGE CORPORATION |
|
| October 18, 2019 |
LFVN / Lifevantage Corp. DEFA14A - - DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Defin |
|
| October 18, 2019 |
LFVN / Lifevantage Corp. DEF 14A - - DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ý Defin |
|
| August 15, 2019 |
Amended and Restated Bylaws, August 9, 2019 LifeVantage Corporation Amended and Restated Bylaws Table of Contents Article I Stockholders 1. |
